Press Releases Year None20232022202120202019201820172016201520142013201220112010200920072006 Date Title 03/14/23 Bellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic Alternatives 02/16/23 Bellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers Symposium 01/31/23 CORRECTION -- Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 01/31/23 Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 01/19/23 Bellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers Symposium
